Yasuhito Tanaka
#161,361
Most Influential Person Now
Researcher
Yasuhito Tanaka's AcademicInfluence.com Rankings
Yasuhito Tanakacomputer-science Degrees
Computer Science
#9310
World Rank
#9780
Historical Rank
Computational Linguistics
#2228
World Rank
#2251
Historical Rank
Machine Learning
#4041
World Rank
#4090
Historical Rank
Artificial Intelligence
#4379
World Rank
#4440
Historical Rank
Download Badge
Computer Science
Yasuhito Tanaka's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Yasuhito Tanaka Influential?
(Suggest an Edit or Addition)Yasuhito Tanaka's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C (2009) (1815)
- Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. (2009) (514)
- Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. (2010) (438)
- A Genetic Variant of Hepatitis B Virus Divergent from Known Human and Ape Genotypes Isolated from a Japanese Patient and Provisionally Assigned to New Genotype J (2009) (429)
- The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. (2015) (353)
- A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades (2002) (336)
- Influence of hepatitis B virus genotypes on the intra‐ and extracellular expression of viral DNA and antigens (2006) (272)
- A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis (2013) (271)
- Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns (1999) (258)
- Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection (2006) (221)
- Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP) (2014) (214)
- Geographical and genetic diversity of the human hepatitis B virus (2010) (213)
- Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas (2007) (209)
- A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. (2005) (188)
- Hepatitis C pharmacogenetics: State of the art in 2010 (2011) (168)
- Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma. (2012) (164)
- A case‐control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D (2004) (161)
- Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma (2009) (158)
- Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. (2004) (155)
- Molecular Evolution of Hepatitis B Virus over 25 Years (2006) (145)
- Hepatitis B Virus Core-Related Antigens as Markers for Monitoring Chronic Hepatitis B Infection (2007) (145)
- Genome-Wide Association Study Confirming Association of HLA-DP with Protection against Chronic Hepatitis B and Viral Clearance in Japanese and Korean (2012) (135)
- Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma. (2006) (132)
- Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization (2019) (131)
- SEN virus infection and its relationship to transfusion‐associated hepatitis (2001) (131)
- Novel subtypes (subgenotypes) of hepatitis B virus genotypes B and C among chronic liver disease patients in the Philippines. (2006) (124)
- Distribution of Hepatitis B Virus Genotypes among Patients with Chronic Infection in Japan Shifting toward an Increase of Genotype A (2009) (124)
- New genotypes of TT virus (TTV) and a genotyping assay based on restriction fragment length polymorphism 1 (1998) (122)
- Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors. (2011) (122)
- Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. (2006) (121)
- Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)* (2013) (114)
- Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study. (2015) (114)
- Gut Dysbiosis Associated With Hepatitis C Virus Infection (2018) (113)
- Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt (2003) (113)
- Effect of Coffee and Green Tea Consumption on the Risk of Liver Cancer: Cohort Analysis by Hepatitis Virus Infection Status (2009) (111)
- Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. (2004) (109)
- Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India (2006) (109)
- Reactivation of hepatitis B virus following rituximab-plus-steroid combination chemotherapy (2010) (94)
- Hepatitis virus infection affects DNA methylation in mice with humanized livers. (2014) (94)
- Exponential Spread of Hepatitis C Virus Genotype 4a in Egypt (2004) (92)
- Detection of Anti-Hepatitis C Virus Effects of Interferon and Ribavirin by a Sensitive Replicon System (2005) (92)
- Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity (2016) (91)
- Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection. (2017) (89)
- JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2 (2016) (85)
- Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement (2020) (85)
- Two subtypes of genotype B (Ba and Bj) of hepatitis B virus in Japan. (2004) (84)
- Risk factors for long‐term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults (2014) (84)
- Circulating let‐7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C (2016) (83)
- Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma (2012) (83)
- Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. (2011) (82)
- The Duration of Lamivudine Therapy for Chronic Hepatitis B: Cessation vs. Continuation of Treatment After HBeAg Seroconversion (2009) (81)
- Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. (2011) (81)
- Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in Arctic indigenous populations. (2007) (81)
- Hepatitis B virus (HBV) genotypes/subgenotypes in China: mutations in core promoter and precore/core and their clinical implications. (2007) (78)
- Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis (2016) (78)
- The rs8099917 Polymorphism, When Determined by a Suitable Genotyping Method, Is a Better Predictor for Response to Pegylated Alpha Interferon/Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28B (2011) (76)
- When Should “I” Consider a New Hepatitis B Virus Genotype? (2008) (76)
- Clinical and Virological Characteristics of Hepatitis B Virus Subgenotypes Ba, C1, and C2 in China (2007) (76)
- Hepatitis B virus and its sexually transmitted infection - an update (2016) (75)
- Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China. (2007) (74)
- ITPA gene variant protects against anemia induced by pegylated interferon‐α and ribavirin therapy for Japanese patients with chronic hepatitis C (2010) (73)
- Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy. (2019) (72)
- Eight genotypes (A–H) of hepatitis B virus infecting patients from San Francisco and their demographic, clinical, and virological characteristics (2004) (71)
- Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. (2004) (70)
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan. (2006) (69)
- Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B. (2019) (68)
- Comparison of genotypes C and D of the hepatitis B virus in Japan: A clinical and molecular biological study (2004) (68)
- Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial (2018) (68)
- Host genetic variants influencing the clinical course of Hepatitis B virus infection (2016) (68)
- Two subtypes (subgenotypes) of hepatitis B virus genotype C: A novel subtyping assay based on restriction fragment length polymorphism. (2005) (65)
- A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide (2015) (65)
- Strategy for glycoproteomics: identification of glyco-alteration using multiple glycan profiling tools. (2009) (65)
- Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis. (2019) (63)
- Multilectin assay for detecting fibrosis-specific glyco-alteration by means of lectin microarray. (2011) (62)
- Mechanisms for Interferon-α-Induced Depression and Neural Stem Cell Dysfunction (2014) (60)
- Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand (2010) (59)
- Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan (2008) (59)
- Combining hepatitis B core‐related and surface antigens at end of nucleos(t)ide analogue treatment to predict off‐therapy relapse risk (2018) (59)
- Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. (2003) (59)
- Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. (2009) (58)
- T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection. (2006) (58)
- Occult hepatitis B in the genotype H‐infected Nahuas and Huichol native Mexican population (2010) (58)
- Application of a Newly Developed High-Sensitivity HBsAg Chemiluminescent Enzyme Immunoassay for Hepatitis B Patients with HBsAg Seroclearance (2013) (57)
- A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins (2017) (57)
- Novel biomarkers for the management of chronic hepatitis B (2020) (57)
- Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B (2012) (57)
- Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan (2009) (57)
- Serum hepatitis B core‐related antigen as a treatment predictor of pegylated interferon in patients with HBeAg‐positive chronic hepatitis B (2016) (56)
- RNA Polymerase Activity and Specific RNA Structure Are Required for Efficient HCV Replication in Cultured Cells (2010) (56)
- Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II) (2009) (56)
- Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b. (2008) (55)
- Origin and Evolution of the Unique Hepatitis C Virus Circulating Recombinant Form 2k/1b (2011) (55)
- Role of IL28B for chronic hepatitis C treatment toward personalized medicine (2014) (54)
- Development and public release of a comprehensive hepatitis virus database (2008) (54)
- Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression* (2014) (52)
- Adefovir Dipivoxil Monotherapy and Combination Therapy with Lamivudine for the Treatment of Chronic Hepatitis B in an Asian Population (2007) (51)
- Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan. (2005) (51)
- Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells (2018) (50)
- High frequency of hepatocellular carcinoma in Mongolia; association with mono‐, or Co‐infection with hepatitis C, B, and delta viruses (2006) (49)
- Association of IL28B variants with response to pegylated‐interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b (2011) (49)
- Novel pH-sensitive multifunctional envelope-type nanodevice for siRNA-based treatments for chronic HBV infection. (2016) (49)
- Molecular epidemiological study of hepatitis B virus among migrant workers from Cambodia, Laos, and Myanmar to Thailand (2010) (48)
- Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5A. (2015) (48)
- Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan (2017) (47)
- Genetic Variation of the IL-28B Promoter Affecting Gene Expression (2011) (47)
- Characterization of novel entecavir resistance mutations. (2015) (47)
- Hepatitis C virus molecular epidemiology in Uzbekistan (2003) (47)
- Fatal reactivation of hepatitis B virus infection in a patient with adult T‐cell leukemia–lymphoma receiving the anti‐CC chemokine receptor 4 antibody mogamulizumab (2015) (47)
- Suppressive effect of oral administration of branched‐chain amino acid granules on oxidative stress and inflammation in HCV‐positive patients with liver cirrhosis (2008) (47)
- Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan (2008) (47)
- Influence of Hepatitis B Virus X and Core Promoter Mutations on Hepatocellular Carcinoma among Patients Infected with Subgenotype C2 (2007) (47)
- Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy (2011) (47)
- Novel Cell Culture-Adapted Genotype 2a Hepatitis C Virus Infectious Clone (2012) (46)
- Analysis of HCV genotypes from blood donors shows three new HCV type 6 subgroups exist in Myanmar. (2004) (46)
- Genome-wide association study identified ITPA / DDRGK 1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C (2011) (46)
- Observation of positive selection within hypervariable regions of a newly identified DNA virus (SEN virus)1 (2002) (45)
- De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry. (2018) (44)
- Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: A collaborative study between Japan, Egypt, and Uzbekistan (2004) (44)
- Genetic variability of hepatitis C virus in South Egypt and its possible clinical implication (2009) (44)
- λ‐Interferons and the single nucleotide polymorphisms: A milestone to tailor‐made therapy for chronic hepatitis C (2010) (44)
- Cure With Interferon‐Free Direct‐Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma From Both East and West (2020) (44)
- Longitudinal Study of Hepatitis Activity and Viral Replication before and after HBeAg Seroconversion in Chronic Hepatitis B Patients Infected with Genotypes B and C (2004) (44)
- Measurement of hepatitis B virus core‐related antigen is valuable for identifying patients who are at low risk of lamivudine resistance (2006) (43)
- Human immunodeficiency virus in Uzbekistan: epidemiological and genetic analyses. (2003) (43)
- No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations (2012) (42)
- Molecular tracing of Japan-indigenous hepatitis E viruses. (2006) (42)
- Glycoproteomic discovery of serological biomarker candidates for HCV/HBV infection-associated liver fibrosis and hepatocellular carcinoma. (2013) (42)
- Development of a prediction model for 10-year risk of hepatocellular carcinoma in middle-aged Japanese: the Japan Public Health Center-based Prospective Study Cohort II. (2012) (42)
- Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection (2017) (42)
- Early dynamics of hepatitis B virus in chimeric mice carrying human hepatocytes monoinfected or coinfected with genotype G (2007) (41)
- Immunobiology of hepatitis B virus infection (2015) (41)
- Tracing the history of hepatitis B virus genotype D in western Japan (2006) (41)
- Relationship between Polymorphisms of the Inosine Triphosphatase Gene and Anaemia or Outcome after Treatment with Pegylated Interferon and Ribavirin (2011) (40)
- Serum aminotransferase level and the risk of hepatocellular carcinoma: a population-based cohort study in Japan (2009) (40)
- Efficacy of daclatasvir/asunaprevir according to resistance-associated variants in chronic hepatitis C with genotype 1 (2016) (40)
- Development of a TT Virus DNA Quantification System Using Real-Time Detection PCR (2000) (40)
- Isoflavone consumption and subsequent risk of hepatocellular carcinoma in a population‐based prospective cohort of Japanese men and women (2009) (40)
- African origin of GB virus C/hepatitis G virus 1 (1998) (40)
- Hepatitis B virus replication could enhance regulatory T cell activity by producing soluble heat shock protein 60 from hepatocytes. (2010) (40)
- Human induced-pluripotent stem cell-derived hepatocyte-like cells as an in vitro model of human hepatitis B virus infection (2017) (39)
- Targeted Induction of Interferon-λ in Humanized Chimeric Mouse Liver Abrogates Hepatotropic Virus Infection (2013) (39)
- Multiple intra‐familial transmission patterns of hepatitis B virus genotype D in north‐eastern Egypt (2012) (38)
- Sofosbuvir–velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals (2018) (38)
- Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia (2008) (38)
- Case–control study for the identification of virological factors associated with fulminant hepatitis B (2009) (37)
- Characteristics of hepatitis B virus genotype G coinfected with genotype H in chimeric mice carrying human hepatocytes. (2008) (37)
- 4′‐modified nucleoside analogs: Potent inhibitors active against entecavir‐resistant hepatitis B virus (2015) (37)
- LecT‐hepa, a glyco‐marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients (2012) (36)
- Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan (2016) (36)
- Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon‐α therapy for patients with chronic hepatitis C (2005) (36)
- Cure with Interferon Free DAA is Associated with Increased Survival in Patients with HCV related HCC from both East and West. (2019) (36)
- Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia (2013) (36)
- Role of HLA-DP Polymorphisms on Chronicity and Disease Activity of Hepatitis B Infection in Southern Chinese (2013) (36)
- Differences of Hepatocellular Carcinoma Patients with Hepatitis B Virus Genotypes of Ba, Bj or C in Japan (2005) (35)
- Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication (2017) (35)
- Transforming growth factor‐beta‐1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection (2003) (35)
- Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy (2017) (35)
- A weak association between occult HBV infection and non-B non-C hepatocellular carcinoma in Japan (2007) (35)
- Enhancement of de novo fatty acid biosynthesis in hepatic cell line Huh7 expressing hepatitis C virus core protein. (2006) (35)
- Positive selection of core 70Q variant genotype 1b hepatitis C virus strains induced by pegylated interferon and ribavirin. (2010) (34)
- Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation. (2021) (34)
- Distribution of HBV genotypes among HBV carriers in Benin:phylogenetic analysis and virological characteristics of HBV genotype E. (2005) (34)
- A new genotype of TT virus (TTV) infection among Colombian native Indians (1999) (34)
- Genetic Association of Human Leukocyte Antigens with Chronicity or Resolution of Hepatitis B Infection in Thai Population (2014) (34)
- Classifying genotype F of hepatitis B virus into F1 and F2 subtypes. (2005) (33)
- 6-Aminohexanoate Oligomer Hydrolases from the Alkalophilic Bacteria Agromyces sp. Strain KY5R and Kocuria sp. Strain KY2 (2007) (33)
- MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells (2019) (33)
- New Susceptibility and Resistance HLA-DP Alleles to HBV-Related Diseases Identified by a Trans-Ethnic Association Study in Asia (2014) (33)
- Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication (2011) (33)
- Molecular evidence of father‐to‐child transmission of hepatitis B virus (2007) (33)
- Slow Evolutionary Rate of GB Virus C/Hepatitis G Virus (1999) (33)
- Novel Type of Hepatitis B Virus Mutation: Replacement Mutation Involving a Hepatocyte Nuclear Factor 1 Binding Site Tandem Repeat in Chronic Hepatitis B Virus Genotype E (2005) (32)
- Genetic diversity of hepatitis B virus as an important factor associated with differences in clinical outcomes. (2007) (32)
- Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan (2008) (32)
- Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy (2017) (32)
- Novel monitoring of hepatitis B reactivation based on ultra‐high sensitive hepatitis B surface antigen assay (2017) (32)
- The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study (2019) (31)
- Reactivation of hepatitis B virus in patients with undetectable HBsAg undergoing chemotherapy for malignant lymphoma or multiple myeloma (2013) (31)
- The Role of Hepatitis B Core-Related Antigen (2019) (31)
- Spread Times of Hepatitis C Virus Estimated by the Molecular Clock Differ among Japan, the United States and Egypt in Reflection of Their Distinct Socioeconomic Backgrounds (2005) (31)
- HBV genotypes in India: do they influence disease severity? (2009) (30)
- Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis (2020) (30)
- Hepatitis B and C virus infection and risk of lymphoid malignancies: A population-based cohort study (JPHC Study). (2015) (30)
- Prevalence of Low Positive Anti‐HCV Antibodies in Blood Donors: Schistosoma mansoni Co‐Infection and Possible Role of Autoantibodies (2006) (29)
- High levels of serum Mac-2-binding protein glycosylation isomer (M2BPGi) predict the development of hepatocellular carcinoma in hepatitis B patients treated with nucleot(s)ide analogues (2018) (29)
- Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia–lymphoma patients with resolved HBV infection following systemic chemotherapy (2015) (29)
- Molecular Epidemiology and Genetic History of Hepatitis C Virus Subtype 3a Infection in Thailand (2013) (29)
- Mechanism of Entecavir Resistance of Hepatitis B Virus with Viral Breakthrough as Determined by Long-Term Clinical Assessment and Molecular Docking Simulation (2009) (29)
- Transmission of hepatitis B virus (HBV) genotypes among Japanese immigrants and natives in Bolivia. (2008) (28)
- Reactivation of hepatitis B virus in a patient with adult T‐cell leukemia–lymphoma receiving the anti‐CC chemokine receptor 4 antibody mogamulizumab (2014) (28)
- Hepatitis B Genotypes in Chronic Hepatitis B and Lamivudine Therapy (2003) (28)
- Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma (2018) (28)
- Host genetic variants influencing the clinical course of hepatitis C virus infection (2016) (28)
- Molecular epidemiology of hepatitis B virus in the United Republic of Tanzania (2006) (28)
- Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study (2018) (27)
- Serum levels of Mac-2 binding protein increase with cardiovascular risk and reflect silent atherosclerosis. (2016) (27)
- Hepatitis B and C Virus Infection and Risk of Pancreatic Cancer: A Population-Based Cohort Study (JPHC Study Cohort II) (2015) (27)
- Impact of viral load of hepatitis C on the incidence of hepatocellular carcinoma: A population-based cohort study (JPHC Study). (2011) (27)
- Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan (2018) (27)
- LecT-Hepa: A triplex lectin-antibody sandwich immunoassay for estimating the progression dynamics of liver fibrosis assisted by a bedside clinical chemistry analyzer and an automated pretreatment machine. (2011) (27)
- Genome‐Wide Association Study Identifies Risk Variants for Lichen Planus in Patients With Hepatitis C Virus Infection (2017) (27)
- Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium (2019) (27)
- Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay (2012) (27)
- Performance of two Real‐Time RT‐PCR assays for quantitation of hepatitis C virus RNA: Evaluation on HCV genotypes 1–4 (2010) (26)
- Molecular epidemiology of hepatitis C virus genotypes in west Mexico. (2010) (26)
- High stability of enzyme immunoassay for hepatitis C virus core antigen-evaluation before and after incubation at room temperature. (2003) (26)
- Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis (2004) (26)
- Abbott RealTime Hepatitis C Virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV Assays for Prediction of Sustained Virological Response to Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients (2008) (26)
- Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009 (2011) (26)
- Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer (2019) (25)
- An Association Between Core Mutations in Hepatitis B Virus Genotype F1b and Hepatocellular Carcinoma in Alaskan Native People (2018) (25)
- Application of a glycoproteomics-based biomarker development method: alteration in glycan structure on colony stimulating factor 1 receptor as a possible glycobiomarker candidate for evaluation of liver cirrhosis. (2014) (25)
- Gianotti-Crosti syndrome caused by acute hepatitis B virus genotype D infection. (2004) (25)
- Predicting relapse after cessation of Lamivudine monotherapy for chronic hepatitis B virus infection. (2004) (25)
- Investigating an outbreak of acute viral hepatitis caused by hepatitis E virus variants in Karachi, South Pakistan (2011) (24)
- Molecular epidemiological study of hepatitis B virus infection in two different ethnic populations from the Solomon Islands (2007) (24)
- A randomized controlled trial of consensus interferon with or without lactoferrin for chronic hepatitis C patients with genotype 1b and high viral load. (2004) (24)
- Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi (2020) (24)
- Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt. (2013) (24)
- Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virus (2018) (23)
- Efficacy and safety results of the phase 2 JNJ-56136379 JADE study in patients with chronic hepatitis B: Interim week 24 data (2020) (23)
- Variations in the core promoter/pre‐core region in HBV genotype C in Japanese and Northern Vietnamese patients (2007) (23)
- Novel Hepatitis B Virus Genotype A Subtyping Assay That Distinguishes Subtype Aa from Ae and Its Application in Epidemiological Studies (2004) (23)
- HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort (2020) (23)
- Hepatitis B virus X protein impairs α‐interferon signaling via up‐regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A (2017) (23)
- Tracing the evolution of hepatitis C virus in the United States, Japan, and Egypt by using the molecular clock. (2005) (23)
- Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease (2018) (22)
- Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection (2020) (22)
- Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene (2012) (22)
- Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti‐viral therapy in patients with chronic hepatitis B (2018) (22)
- Strong prediction of virological response to combination therapy by IL28B gene variants rs12979860 and rs8099917 in chronic hepatitis C genotype 4 (2014) (22)
- Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment (2018) (22)
- Molecular characterization of hepatitis B virus isolates from Zimbabwean blood donors (2011) (21)
- The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter study (2020) (21)
- Efficient Engraftment of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells in uPA/SCID Mice by Overexpression of FNK, a Bcl-xLMutant Gene (2015) (21)
- JSH Guidelines for the Management of Hepatitis C Virus Infection, 2019 Update; Protective Effect of Antiviral Therapy against Hepatocarcinogenesis (2020) (21)
- East Asia expert opinion on treatment initiation for chronic hepatitis B (2020) (21)
- Replication and infectivity of a novel genotype 1b hepatitis C virus clone (2012) (21)
- A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan (2010) (21)
- Heterogeneity in E2 region of GBV‐C/hepatitis G virus and hepatitis C virus (1998) (21)
- Factors associated with the effect of interferon‐α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B (2015) (21)
- Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease (2018) (21)
- Property of hepatitis B virus replication in Tupaia belangeri hepatocytes. (2016) (21)
- Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens (2015) (20)
- Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma: two case reports (2010) (20)
- Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C (2018) (20)
- Influences on hepatitis B virus replication by a naturally occurring mutation in the core gene. (2007) (20)
- Evolutionary analysis of hepatitis C virus gene sequences from 1953 (2013) (20)
- Development of real‐time detection direct test for hepatitis B virus and comparison with two commercial tests using the WHO international standard (2003) (20)
- Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data. (2020) (19)
- A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C. (2006) (19)
- Host genetic variations associated with disease progression in chronic hepatitis C virus infection (2018) (19)
- Virological features of hepatitis B virus‐associated nephropathy in Japan (2007) (19)
- TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus by interferon-free therapy (2018) (19)
- Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients (2021) (19)
- Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus‐related chronic liver disease (2004) (18)
- What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? (2008) (18)
- Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma : Preponderance of genotype F. Commentary (2007) (18)
- Mac‐2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection (2019) (18)
- Hepatitis B caused by a hepatitis B surface antigen escape mutant (2008) (18)
- Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy (2013) (18)
- MicroRNA‐493‐5p‐mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion (2019) (18)
- Add‐on therapy of pitavastatin and eicosapentaenoic acid improves outcome of peginterferon plus ribavirin treatment for chronic hepatitis C (2013) (18)
- High sensitivity assay using serum sample for IL28B genotyping to predict treatment response in chronic hepatitis C patients (2010) (18)
- Efficacy of direct‐acting antiviral treatment in patients with compensated liver cirrhosis: A multicenter study (2018) (18)
- Effectiveness and safety of community-based treatment with sofosbuvir plus ribavirin for elderly patients with genotype 2 chronic hepatitis C. (2017) (18)
- Intrahepatic Cross-Presentation and Hepatocellular Antigen Presentation Play Distinct Roles in the Induction of Hepatitis B Virus-Specific CD8+ T Cell Responses (2018) (18)
- Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by In Vitro and In Vivo Infection (2015) (18)
- Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation. (2016) (17)
- Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversion (2007) (17)
- Prediction of response to pegylated interferon/ribavirin combination therapy for chronic hepatitis C genotype 1b and high viral load (2012) (17)
- HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication. (2019) (17)
- Identification of the novel 3′ UTR sequences of human IL-21 mRNA as potential targets of miRNAs (2017) (17)
- Plasma Levels of Adiponectin and Primary Liver Cancer Risk in Middle-Aged Japanese Adults with Hepatitis Virus Infection: A Nested Case–Control Study (2013) (17)
- Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNA. (2020) (17)
- Serum interferon‐gamma‐inducible protein‐10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C (2014) (17)
- Cross-Protection of Hepatitis B Vaccination among Different Genotypes (2020) (17)
- Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy (2018) (17)
- Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody (2017) (16)
- Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion. (2011) (16)
- Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan (2019) (16)
- The antiviral effects of human microRNA miR‐302c‐3p against hepatitis B virus infection (2019) (16)
- Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha‐fetoprotein assessment (2016) (15)
- Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy (2020) (15)
- 2'-Fluoro-6'-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: in vitro anti-HBV activity against the lamivudine-entecavir resistant triple mutant and its mechanism of action. (2013) (15)
- Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma. (2020) (15)
- Hepatitis B surface gene variants isolated from blood donors with overt and occult HBV infection in north eastern Egypt (2015) (15)
- Relationship between inosine triphosphate genotype and outcome of extended therapy in hepatitis C virus patients with a late viral response to pegylated‐interferon and ribavirin (2014) (15)
- Characterization of Streptococcus pyogenes Isolated from Balanoposthitis Patients Presumably Transmitted by Penile-Oral Sexual Intercourse (2010) (15)
- The Effects of IL-28B and ITPA Polymorphisms on Treatment of Hepatitis C Virus Genotype 6 (2011) (15)
- Evaluation of 8‐week glecaprevir/pibrentasvir treatment in direct‐acting antiviral‐naïve noncirrhotic HCV genotype 1 and 2infected patients in a real‐world setting in Japan (2019) (15)
- Interferon-β response is impaired by hepatitis B virus infection in Tupaia belangeri. (2017) (14)
- Plasma Isoflavones and Risk of Primary Liver Cancer in Japanese Women and Men with Hepatitis Virus Infection: A Nested Case–Control Study (2014) (14)
- Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection (2007) (14)
- Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma (2016) (14)
- Daclatasvir and asunaprevir for genotype 1b chronic hepatitis C patients with chronic kidney disease (2017) (14)
- The rs 8099917 Polymorphism , When Determined by a Suitable Genotyping Method , Is a Better Predictor for Response to Pegylated Alpha Interferon / Ribavirin Therapy in Japanese Patients than Other Single Nucleotide Polymorphisms Associated with Interleukin-28 B † (2011) (14)
- Identification of a novel long-acting 4'-modified nucleoside reverse transcriptase inhibitor against HBV. (2020) (14)
- New combination test for hepatitis C virus genotype and viral load determination using Amplicor GT HCV MONITOR test v2.0. (2005) (14)
- Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment. (2018) (14)
- A novel glycobiomarker, Wisteria floribunda agglutinin macrophage colony‐stimulating factor receptor, for predicting carcinogenesis of liver cirrhosis (2016) (13)
- Production of Infectious Chimeric Hepatitis C Virus Genotype 2b Harboring Minimal Regions of JFH-1 (2011) (13)
- Novel Evidence of HBV Recombination in Family Cluster Infections in Western China (2012) (13)
- Increasing genetic diversity of hepatitis C virus in haemophiliacs with human immunodeficiency virus coinfection. (2007) (13)
- A Noncanonical mu-1A-Binding Motif in the N Terminus of HIV-1 Nef Determines Its Ability To Downregulate Major Histocompatibility Complex Class I in T Lymphocytes (2012) (13)
- Real-World Clinical Application of 12-Week Sofosbuvir/Velpatasvir Treatment for Decompensated Cirrhotic Patients with Genotype 1 and 2: A Prospective, Multicenter Study (2020) (13)
- Murine neonatal ketogenesis preserves mitochondrial energetics by preventing protein hyperacetylation (2021) (12)
- Usefulness of an artificial intelligence system for the detection of esophageal squamous cell carcinoma evaluated with videos simulating overlooking situation (2021) (12)
- Effect of hepatitis B virus subgenotype on antiviral response in nucleoside‐treated hepatitis B envelope antigen‐positive patients (2018) (12)
- Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes (2017) (12)
- Hepatic IFNL4 expression is associated with non‐response to interferon‐based therapy through the regulation of basal interferon‐stimulated gene expression in chronic hepatitis C patients (2017) (12)
- Biological properties of purified recombinant HCV particles with an epitope-tagged envelope. (2010) (12)
- Lack of Integrated TT Virus (TTV) Genomes Into Cellular DNA in Infected Human Hematopoietic Cells (2000) (12)
- A reduction in selective immune pressure during the course of chronic hepatitis C correlates with diminished biochemical evidence of hepatic inflammation. (2007) (12)
- Peginterferon Therapy in Children With Chronic Hepatitis C: A Nationwide, Multicenter Study in Japan, 2004–2013 (2016) (12)
- Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated‐interferon plus ribavirin therapy for chronic hepatitis C (2013) (12)
- Clinical phase 1b study results for safety, pharmacokinetics and efficacy of ND-L02-s0201, a novel targeted lipid nanoparticle delivering HSP47 SIRNA for the treatment of Japanese patients with advanced liver fibrosis (2018) (12)
- Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B (2021) (12)
- Molecular evolutionary analysis predicts the incidence of hepatocellular carcinoma in the United States and Japan (2004) (12)
- Prospective Nationwide Observational Study of Hepatitis B Virus (HBV) DNA Monitoring and Preemptive Antiviral Therapy for HBV Reactivation in Patients with B-Cell Non-Hodgkin Lymphoma Following Rituximab Containing Chemotherapy: Results of Interim Analysis. (2012) (12)
- Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients (2021) (12)
- Characteristics of escape mutations from occult hepatitis B virus infected patients with hematological malignancies in South Egypt (2017) (11)
- Specific mutations of basal core promoter are associated with chronic liver disease in hepatitis B virus subgenotype D1 prevalent in Turkey (2013) (11)
- Clinical significance of hepatitis B virus (HBV)-DNA monitoring to detect HBV reactivation after systemic chemotherapy. (2011) (11)
- Novel findings for the development of drug therapy for various liver diseases: Genetic variation in IL-28B is associated with response to the therapy for chronic hepatitis C. (2011) (11)
- Longitudinal profiles of highly sensitive hepatitis B surface antigen levels: re‐evaluation of HBsAg seroclearance (2016) (11)
- Serum Wisteria floribunda agglutinin‐positive Mac‐2 binding protein level as a diagnostic marker of hepatitis B virus‐related hepatocellular carcinoma (2018) (11)
- Hepatitis B virus genotype G is an extremely rare genotype in Japan. (2004) (11)
- Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C (2015) (11)
- Comparison of LecT-Hepa and FibroScan for assessment of liver fibrosis in hepatitis B virus infected patients with different ALT levels. (2012) (10)
- Accidental exposure to HCV antibody‐positive blood in hospital and pre‐emptive one‐shot interferon alpha‐2b treatment (2007) (10)
- Effect of hepatitis B virus reverse transcriptase variations on entecavir treatment response. (2014) (10)
- Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease (2019) (10)
- Type I Interferon Signaling Prevents Hepatitis B Virus-Specific T Cell Responses by Reducing Antigen Expression (2018) (10)
- Small Interfering RNA Screening for the Small GTPase Rab Proteins Identifies Rab5B as a Major Regulator of Hepatitis B Virus Production (2019) (10)
- microRNAs and Hepatitis B. (2015) (10)
- Novel strategies for the early diagnosis of hepatitis B virus reactivation (2021) (9)
- Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy. (2022) (9)
- Differential Expression of CX3CL1 in Hepatitis B Virus-Replicating Hepatoma Cells Can Affect the Migration Activity of CX3CR1+ Immune Cells (2015) (9)
- Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C (2016) (9)
- Hepatitis B virus reactivation in a myeloma patient with resolved infection who received daratumumab-containing salvage chemotherapy (2020) (9)
- Response‐guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2 (2012) (9)
- Bardoxolone methyl as a novel potent antiviral agent against hepatitis B and C viruses in human hepatocyte cell culture systems. (2019) (9)
- Antiviral activity of novel 2'-fluoro-6'-methylene-carbocyclic adenosine against wild-type and drug-resistant hepatitis B virus mutants. (2011) (9)
- Prevalence of SEN viruses among injection drug users in the San Francisco Bay area. (2003) (9)
- Identification of microRNA‐96‐5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma (2021) (9)
- α‐Fetoprotein is a surrogate marker for predicting treatment failure in telaprevir‐based triple combination therapy for genotype 1b chronic hepatitis C Japanese patients with the IL28B minor genotype (2014) (8)
- Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma (2017) (8)
- Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019 (2021) (8)
- [Evaluation of hepatitis B virus genotyping EIA kit]. (2009) (8)
- Development of new IL28B genotyping method using Invader Plus assay (2012) (7)
- Association of IL28B polymorphisms with virological response to peginterferon and ribavirin therapy in children and adolescents with chronic hepatitis C (2014) (7)
- Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy (2012) (7)
- Molecular epidemiology of co‐infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe (2017) (7)
- Prevalence of TT Virus and GBV-C Infections among Patients with Liver Diseases and the General Population in Shanghai, China (2004) (7)
- Cross-species transmission of gibbon and orangutan hepatitis B virus to uPA/SCID mice with human hepatocytes. (2011) (7)
- [Fundamental and clinical evaluation of hepatitis B virus core-related antigen assay by LUMIPULSE f]. (2006) (7)
- Hepatitis B virus‐related hepatocellular carcinoma in young adults: Efficacy of nationwide selective vaccination (2020) (7)
- Bile acid dysmetabolism in the gut‐microbiota‐liver axis under hepatitis C virus infection (2021) (7)
- Establishment of a novel hepatitis B virus culture system using immortalized human hepatocytes (2020) (7)
- Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection (2004) (7)
- CMCdG, a Novel Nucleoside Analog with Favorable Safety Features, Exerts Potent Activity against Wild-Type and Entecavir-Resistant Hepatitis B Virus (2019) (7)
- A Novel Drug-Resistant HIV-1 Circulating Recombinant Form CRF76_01B Identified by Near Full-Length Genome Analysis. (2016) (7)
- GB virus C/hepatitis G virus infection among patients with hepatocellular carcinoma (1997) (7)
- Is antiviral prophylaxis necessary to prevent hepatitis B virus (HBV) reactivation in patients with HBV-resolved infection receiving rituximab-containing chemotherapy? (2013) (7)
- Suppressor of cytokine signal 3 and IL28 genetic variation predict the viral response to peginterferon and ribavirin (2011) (7)
- Influence of Genes Suppressing Interferon Effects in Peripheral Blood Mononuclear Cells during Triple Antiviral Therapy for Chronic Hepatitis C (2015) (7)
- Inhibitory Effect of a Human MicroRNA, miR-6133-5p, on the Fibrotic Activity of Hepatic Stellate Cells in Culture (2020) (7)
- [Clinical evaluation of a newly developed high-sensitive detection of hepatitis B virus surface antigen by a semi-automated immune complex transfer chemiluminescent enzyme immunoassay]. (2013) (6)
- Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy (2021) (6)
- Suppression of hepatitis B surface antigen production by combination therapy with nucleotide analogues and interferon in children with genotype C hepatitis B virus infection (2018) (6)
- Seamless support from screening to anti-HCV treatment and HCC/ decompensated cirrhosis: Subsidy programs for HCV elimination. (2021) (6)
- Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B (2020) (6)
- Variations in the Viral NS5B Region in Japanese Patients with Chronic Hepatitis C Virus Genotype 1b Infection (2006) (6)
- Recommendation of lamivudine‐to‐entecavir switching treatment in chronic hepatitis B responders: Randomized controlled trial (2011) (6)
- Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen (2020) (6)
- Factors associated with longitudinal changes in serum concentrations of Mac-2 binding protein: A prospective 3-year observational study. (2019) (6)
- Tracing the Spread of Hepatitis C Virus in Turkey: A Phylogenetic Analysis (2013) (6)
- Antiviral therapy for hepatitis B virus during second pregnancies (2018) (6)
- Outcome of Double-Filtration Plasmapheresis plus Interferon Treatment in Nonresponders to Pegylated Interferon plus Ribavirin Combination Therapy (2013) (6)
- Smoking is a risk factor for development of adult T-cell leukemia/lymphoma in Japanese human T-cell leukemia virus type-1 carriers (2016) (6)
- 7-Deaza-7-fluoro modification confers on 4'-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safety. (2020) (6)
- A human PSMB11 variant affects thymoproteasome processing and CD8+ T cell production. (2017) (6)
- Impact of a single nucleotide polymorphism upstream of the IL28B gene in patients positive for anti‐HCV antibody in an HCV hyperendemic area in Japan (2014) (6)
- Screening of microRNAs for a repressor of hepatitis B virus replication (2018) (6)
- [Quantitative analysis of hepatitis B surface antigen as a clinical marker]. (2011) (6)
- Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis (2017) (5)
- Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR (2021) (5)
- Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy (2015) (5)
- Hepatitis C Virus Genotype 2 May Not Be Detected by the Cobas AmpliPrep/Cobas TaqMan HCV Test, Version 1.0 (2013) (5)
- The Technology to Produce Thermoplastic Elastomer Based on Waste Rubber (2003) (5)
- Restoration of type I interferon signaling in intrahepatically primed CD8+ T cells promotes functional differentiation (2021) (5)
- Clinical Evaluation of Hepatocarcinogenesis and Outcome Using a Novel Glycobiomarker Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA+-M2BP) in Chronic Hepatitis C with Advanced Fibrosis. (2018) (5)
- Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins (2021) (5)
- Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis (2021) (5)
- Japanese case of hepatitis B virus genotypes C/D hybrid (2007) (5)
- Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase AID (2013) (5)
- Loss of skeletal muscle mass affects the incidence of minimal hepatic encephalopathy: a case control study (2020) (5)
- Double-Filtration Plasmapheresis plus Interferon-β for HCV-1b Patients with Non-Sustained Virological Response to Previous Combination Therapy (2011) (5)
- Crystallization and X-ray diffraction analysis of nylon-oligomer hydrolase (NylC) from Agromyces sp. KY5R. (2011) (4)
- Enhanced release of prostaglandin D2 during re-incubation of RAW 264.7 macrophage-like cells after treatment of both lipopolysaccharide and non-steroidal anti-inflammatory drugs. (2004) (4)
- PCR‐probe capture hybridization assay and statistical model for SEN virus prevalence estimation (2004) (4)
- Amino acid substitutions in NS5A region of GB virus C and response to interferon therapy (1999) (4)
- Impaired cytotoxic T lymphocyte inductivity by dendritic cells derived from patients with hepatitis C virus‐positive hepatocellular carcinoma (2007) (4)
- Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine. (2021) (4)
- Tolloid‐Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling (2020) (4)
- JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study (2020) (4)
- Favorable factors for re‐treatment with pegylated interferon α2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus (2011) (4)
- Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C (2013) (4)
- Interleukin 1β gene polymorphism and hepatitis C virus‐related hepatocellular carcinoma (2003) (4)
- The reduction of miR146b-5p in monocytes and T cells could contribute to the immunopathogenesis of hepatitis C virus infection (2019) (4)
- Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2 (2016) (4)
- [Evaluation and application of a newly developed highly sensitive HBsAg chemiluminescent enzyme immunoassay for chronic hepatitis B patients]. (2010) (4)
- Screening siRNAs against host glycosylation pathways to develop novel antiviral agents against hepatitis B virus (2020) (4)
- Clinical evaluation of a novel and highly sensitive immunoassay for anti‐hepatitis B core antigen using a fully automated immunochemical analyzer (2018) (4)
- Impact of determination of hepatitis B virus subgenotype and pre‐core/core‐promoter mutation for the prediction of acute exacerbation of asymptomatic carriers (2009) (4)
- Quantitative hepatitis B surface antigen in predicting recurrence of hepatitis B-related hepatocellular carcinoma after liver transplantation (2018) (4)
- 1169 GENETIC POLYMORPHISM IN IL28B PREDICTS NULL VIROLOGICAL RESPONSE TO PEGYLATED-INTERFERON PLUS RIBAVIRIN THERAPY FOR CHRONIC HEPATITIS C (2010) (3)
- Hepatic failure in pregnancy successfully treated by online hemodiafiltration: Chronic hepatitis B virus infection without viral genome mutation (2013) (3)
- A genome‐wide association study identifying SVEP1 variant as a predictor of response to tolvaptan for cirrhotic ascites (2021) (3)
- [Comparative Study for Anti-Hepatitis B Surface Antigen Titers Based on Two Measurement Methods: Using Monoclonal Antibodies Isolated from Hepatitis B Vaccinated Recipients]. (2015) (3)
- Case of hepatitis B virus reactivation after ibrutinib therapy in which the patient remained negative for hepatitis B surface antigens throughout the clinical course (2020) (3)
- Successful treatment of adult-onset type II citrullinemia with a low-carbohydrate diet and l-arginine after DNA analysis produced a definitive diagnosis (2020) (3)
- Hepatitis B Virus Core-related Antigens as a Marker for Monitoring of Chronic Hepatitis B Infection (2007) (3)
- P1118 NO EFFECT OF FALDAPREVIR ON RENAL FUNCTION IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: POOLED DATA FROM TWO PHASE III TRIALS (2014) (3)
- Universal vaccination of hepatitis B virus vaccine (2012) (3)
- Prophylactic antiviral therapy for HBsAg-positive patients with DLBCL treated with rituximab-containing chemotherapy. (2021) (3)
- Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation (2022) (3)
- Optimal management of lenvatinib therapy for patients with unresectable hepatocellular carcinoma by balancing the therapeutic effect with the relative dose intensity (2021) (3)
- 726 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES GENETIC VARIANTS IN THE HLA-DP LOCUS ASSOCIATED WITH CHRONIC HEPATITIS B (2010) (3)
- Changes in mitochondrial activity during enlargement of mung bean root cells (1973) (3)
- Postexposure Prophylactic Effect of Hepatitis B Virus (HBV)-Active Antiretroviral Therapy against HBV Infection (2014) (3)
- Clarification of interspousal hepatitis C virus infection in acute hepatitis C patients by molecular evolutionary analyses: Consideration on sexual and non‐sexual transmission between spouses (2011) (3)
- Successful treatment of three patients with human immunodeficiency virus and hepatitis C virus genotype 1b co-infection by daclatasvir plus asunaprevir (2017) (3)
- [Risk Management of HBV Reactivation: Construction of Check System]. (2015) (3)
- Liver fibrosis improvement assessed by magnetic resonance elastography and Mac‐2‐binding protein glycosylation isomer in patients with hepatitis C virus infection receiving direct‐acting antivirals (2021) (3)
- Modified albumin–bilirubin grade to predict eligibility for second-line therapies at progression on sorafenib therapy in hepatocellular carcinoma patients (2021) (3)
- Analysis of Hepatitis B Virus Genotype D in Greenland Suggests the Presence of a Novel Quasi-Subgenotype (2021) (3)
- Virological characteristics of hepatitis B genotype G/A2 recombination virus in Japan (2016) (3)
- Hepatitis C virus recurrence in two patients who achieved sustained viral response with interferon-free direct-acting antiviral therapy: reinfection or relapse? (2019) (2)
- Droplet digital PCR assay provides intrahepatic HBV cccDNA quantification tool for clinical application (2022) (2)
- Free energy profile of permeation of Entecavir through Hepatitis B virus capsid studied by molecular dynamics calculation (2020) (2)
- Interleukin 1beta gene polymorphism and hepatitis C virus-related hepatocellular carcinoma. (2003) (2)
- Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar (2017) (2)
- Genome-Wide Association Study Identi fi es TLL 1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection (2017) (2)
- The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency (2021) (2)
- Pretreatment prediction of the outcome of response-guided peginterferon-α and ribavirin therapy for chronic hepatitis C (2014) (2)
- N-glycan structures of Wisteria floribunda agglutinin-positive Mac2 binding protein in the serum of patients with liver fibrosis†. (2021) (2)
- Reduction of T-Box 15 gene expression in tumor tissue is a prognostic biomarker for patients with hepatocellular carcinoma (2020) (2)
- Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy (2017) (2)
- [Clinical manifestations of hepatitis B virus genotype]. (2006) (2)
- The value of serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker for hepatitis C virus-related complications after systemic chemotherapy (2016) (2)
- ACUTE VIRAL HEPATITIS EPIDEMIC CAUSED BY HEPATITIS E VIRUS VARIANTS: VIGILANT SAMPLING AND APT TEST INFLUENCE DIAGNOSIS (2009) (2)
- P1125 PHARMACOKINETIC-RESPONSE ANALYSIS OF FALDAPREVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: A POOLED ANALYSIS OF TWO PHASE III TRIALS (2014) (2)
- Fluorescence-based biochemical analysis of human hepatitis B virus reverse transcriptase activity. (2020) (2)
- Universal hepatitis B vaccination: pros and cons (2009) (2)
- Prediction of Response to Pegylated Interferon/Ribavirin Combination Therapy for Chronic Hepatitis C Genotypes 2a and 2b and High Viral Load (2013) (2)
- Clinical usefulness of a newly developed high-sensitive hepatitis B surface antigen (HBsAg) assay for monitoring hepatitis B reactivation (2019) (2)
- [Latest Treatment of Viral Hepatitis--Overcoming Hepatitis C and Reactivation of Hepatitis B]. (2016) (2)
- Erratum to: Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis (2016) (2)
- [Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics: 1. Reactivation of hepatitis B virus and hepatitis C virus following immunosuppressive therapy]. (2014) (2)
- 1178 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES IL28B ASSOCIATED WITH RESPONSE TO PEGYLATED INTERFERON-ALFA AND RIBAVIRIN THERAPY FOR JAPANESE PATIENTS WITH CHRONIC HEPATITIS C (2010) (2)
- A case of acute hepatitis C in which transmission of HCV strain from a patient with chronic hepatitis C was demonstrated (2006) (2)
- The reply to the correspondence entitled "Understanding HBcrAg components helps the better interpretation of clinical HBcrAg assay results" by Hong, X. and Hu, J. (2021) (2)
- MicroRNA and liver cancer (2020) (2)
- Co-continuous structural effect of size-controlled macro-porous glass membrane on extracellular vesicle collection for the analysis of miRNA (2021) (2)
- CMCdG, a novel nucleoside analog, exerts potent activity against wild-type and entecavir-resistant HBV with favorable safety feature (2019) (2)
- [Hepatitis B Virus Infection: Current Management and Prevention]. (2016) (2)
- Factors of Response to Pegylated Interferon/Ribavirin Combination Therapy and Mechanism of Viral Clearance (2013) (2)
- Interleukin28B and Inosine Triphosphatase Help to Personalize Hepatitis C Treatment (2011) (2)
- Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection (2021) (2)
- A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C (2021) (2)
- Influence of renal dysfunction on dose reduction and virologic efficacy of regimens combining ribavirin and all‐oral direct acting antivirals in patients with chronic hepatitis C virus infection (2019) (2)
- Analysis of Hepatitis B virus genotype D in Greenland suggests presence of a novel subgenotype (2020) (1)
- Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic HCV infection in a real-word setting: a large, multicenter study from Japan. (2020) (1)
- Hepatitis B genotypes and long-term lamivudine therapy (2003) (1)
- Blocking neddylation elicits antiviral effect against hepatitis B virus replication (2021) (1)
- Serum miR-192-5p levels predict the efficacy of pegylated interferon therapy for chronic hepatitis B (2021) (1)
- Clinical effectiveness of a newly developed and fully automated high-sensitive hepatitis B core-related antigen assay for monitoring nucleos(t)ide analogues therapy in hepatitis B envelope antigen-negative patients (2020) (1)
- Evaluation of loss of heterozygosity before and after interferon therapy in patients with hepatitis C virus infection who developed hepatocellular carcinoma during follow up (2003) (1)
- Form 2 k / 1 b Hepatitis C Virus Circulating Recombinant Origin and Evolution of the Unique (2012) (1)
- Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C (2017) (1)
- Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab‐containing chemotherapy (2014) (1)
- Recommendation of medical consultation and/or treatment by pharmacists to patients with chronic hepatitis C who visited health insurance pharmacies (2017) (1)
- [False positive serum des-gamma-carboxy prothrombin after resection of hepatocellular carcinoma]. (2007) (1)
- Mac‐2 binding protein and its glycan isomer: Where does it come from? Where is it going? (2021) (1)
- [Clinical evaluation of a novel HBsAg quantitative assay]. (2007) (1)
- Plasma Iso fl avones and Risk of Primary Liver Cancer in JapaneseWomenandMenwithHepatitis Virus Infection : A Nested Case – Control Study (2015) (1)
- [Evaluation of high-sensitivity HBsAg quantitative assay for HBV genotype]. (2009) (1)
- 1171 IDENTIFICATION OF GENETIC VARIANTS OF THE IL28B ASSOCIATED WITH SPONTANEOUS CLEARANCE OF HEPATITIS C VIRUS IN JAPANESE POPULATION (2010) (1)
- Hepatitis B Core Related Antigen in Sera is the Surrogate Marker for HBV Covalently Closed Circular DNA (2016) (1)
- In vitro replication competence of a hepatitis B genotype D/A recombinant virus: dissimilar biological behaviour regarding its parental genotypes. (2013) (1)
- How are HBV-specific CD8+ T-cell responses induced? (2018) (1)
- Efficacy and safety of elbasvir and grazoprevir for chronic hepatitis C patients with chronic kidney disease (2017) (1)
- IDDF2018-ABS-0110 Efficacy and safety of SOFOSBUVIR/VELPATASVIR plus RIBAVIRIN for 12 or 24 weeks in genotype 1 or 2 HCV-INFECTED japanese patients with prior treatment failure to daa-based regimens (2018) (1)
- Clinical evaluation of a newly developed chemiluminescent enzyme immunoassay in Japan for hepatitis C virus core antigen. (2019) (1)
- [Natural history of hepatitis C virus infection]. (2015) (1)
- Anti-nuclear antibody and a granuloma could be biomarkers for iCIs-related hepatitis by anti-PD-1 treatment (2021) (1)
- Cost-Effectiveness Modeling Study of boceprevir for the treatment of patients with genotype 1 chronic hepatitis C virus infection in Hong Kong (2013) (1)
- [Clinical examinations based on nucleic acids of hepatitis viruses]. (2006) (1)
- Early recurrence of hepatocellular carcinoma in patients with HCV infection followed by transient elastography for two years after successful treatment with daclatasvir plus asunaprevir (2017) (1)
- A case of primary hepatic leiomyosarcoma treated with multi-line chemotherapy (2021) (1)
- [Clinical Significance of Novel Serum Biomarkers in the Management of Liver Diseases]. (2017) (1)
- GB virus C/hepatitis G virus infection among Japanese patients with hematological diseases (1997) (1)
- Risk stratification for advanced colorectal neoplasia based on the findings of the index and first surveillance colonoscopies (2021) (1)
- 1184 Inhibition of hepatitis B virus replication by small interfering RNAs (2003) (1)
- All-atom molecular dynamics study of hepatitis B virus containing pregenome RNA in solution. (2021) (1)
- A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assays. (2022) (1)
- 328: REAL-WORLD TREATMENT OUTCOME WITH PROTEASE INHIBITOR (PI) VS NON-PI DIRECT ACTING ANTIVIRALS (DAAS) IN DECOMPENSATED HCV CIRRHOSIS: A REAL-C STUDY (2022) (1)
- Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia (2019) (1)
- Partial purification and properties of phosphatidylethanolamine methyltransferase system from mouse liver microsomes (1982) (1)
- Sustained virologic response (SVR) to direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC): a systematic review and meta-analysis (2018) (1)
- Drug Discovery Study Aimed at a Functional Cure for HBV (2022) (1)
- Transition and problems of hepatitis B virus genotypes among patients with acute and chronic infection in Japan (2008) (1)
- Mutation in the Box a Increases the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Genotype C Infection (2005) (1)
- Improvement of Gut Diversity and Composition after Direct-Acting Antivirals in HCV-Infected Patients with or without HIV Coinfection. (2021) (1)
- [Epidemiology of intrafamilial transmission of hepatitis C virus by molecular evolutionary analysis]. (2004) (0)
- Familial clustering of GB virus C/hepatitis G virus infection among the Jewish population in Uzbekistan (1997) (0)
- 23rd Annual Conference of APASL March 12–15, 2014, Brisbane, Australia (2014) (0)
- Contents Vol. 35, 2017 (2017) (0)
- Improved basic performance of iTACT-HBcrAg assay. (2023) (0)
- Subject Index Vol. 46, 2003 (2003) (0)
- 510 PROGRESSION OF CHRONIC HEPATITIS B TO CIRRHOSIS AND HEPATOCELLULAR CARCINOMA BY AGE, SEX, DISEASE ACTIVITY, AND TREATMENT STATUS USING AASLD CRITERIA (2021) (0)
- Evidence of serologic activity in chronic hepatitis B after surface antigen (HBSAG) seroclearance (2011) (0)
- Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study (2021) (0)
- Low HBcrAg and HBsAg levels identify patients most likely to achieve sustained response after nucleos(t)ide analogue cessation: results from a global individual patient data meta-analysis (create study) (2020) (0)
- Hepatitis C Virus Infection (2019) (0)
- PREDICTION OF RESPONSE TO PEGYLATED-INTERFERON FOR CHRONIC HEPATITIS C: IMPACT OF SNPS NEAR THE IL28B GENE AND MUTATIONS IN THE ISDR OF HCV REVEALED BY DATA MINING ANALYSIS (2010) (0)
- The Relation between Inosine Triphosphatase Gene Variants and Anemia and Thrombocytopenia Induced by Combined Pegylated Interferon-Alfa and Ribavirin Therapy among Chronic Hepatitis C Patients in Egypt (2015) (0)
- [HBV--clinical impact of HBV genotypes]. (2003) (0)
- Present and Future of Pediatric Hepatology (2017) (0)
- (AID) Activation-induced Cytidine Deaminase Infection via a Cytidine Deaminase Trigger Restriction of Hepatitis B Virus ! Interleukin-1 and Tumor Necrosis Factor- Microbiology: (2014) (0)
- Lamivudine treatment during pregnancy successfully prevented mother-to-child transmission of hepatitis B virus infection (2012) (0)
- The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis C (2022) (0)
- 380 REACTIVATION OF HEPATITIS B VIRUS IN HBSAG NEGATIVE PATIENTS UNDERGOING CHEMOTHERAPY FOR LYMPHOMA AND MULTIPLE MYELOMA: PROSPECTIVE SINGLE-INSTITUTION STUDY (2011) (0)
- 563 New combination test for hepatitis C virus genotype and amplicor GT HCV monitor test V 2.0 (2003) (0)
- CLINICAL — LIVER Consumption of n-3 Fatty Acids and Fish Reduces Risk of Hepatocellular Carcinoma (2012) (0)
- Characterization of innate immune response to hepatitis B virus genotype F acute infection in tree shrew (Tupaia belangeri) model (2022) (0)
- [Preemptive therapy for HBV reactivation by serial HBV-DNA monitoring]. (2010) (0)
- Subtypes of hepatitis B virus genotype C in China: distribution and characteristics including two new subgenotypes. (2006) (0)
- 457PNab-paclitaxel in combination with carboplatin versus docetaxel in chemotherapy-naïve with advanced non-small-cell lung cancer aged 75 years old or more: Retrospective cohort study (2017) (0)
- Complex structural variations in non-human primate hepatitis B virus (2021) (0)
- IS-PD1-1_H Clinical significance of high- sensitive HB core-related antigen assay in patients with resolved HBV infection after HBV reactivation (2020) (0)
- The impact of the covalently closed circular DNA level on recurrence of hepatocellular carcinoma after initial hepatectomy: an analysis of patients with resolved hepatitis B virus infection. (2022) (0)
- Narrow-band imaging with magnification in perianal Paget disease. (2021) (0)
- Efficacy of regimens combining direct acting antiviral agents for hepatitis C virus recombinant form RF1_2k/1b (2018) (0)
- [Tailor-made strategy in HCV treatment]. (2012) (0)
- Blocking neddylation elicits antiviral effect against hepatitis B virus replication (2021) (0)
- Efficacy and Safety of Glecaprevir/Pibrentasvir Combination Therapy in Genotype 1b Chronic Hepatitis C Patients with and without Cirrhosis Undergoing Hemodialysis (2018) (0)
- Factors associated with rapid fibrosis progression. (2015) (0)
- P6218Serum levels of Mac-2 binding protein reflect silent atherosclerosis (2017) (0)
- A Genome-Wide Association Study Identifying SVEP1 Variant as a Predictor of Response to Tolvaptan for Cirrhotic Ascites (2021) (0)
- 837 PREDICTION OF RESPONSE TO PEG-IFN/RBV THERAPY FOR CHRONIC HEPATITIS C GENOTYPE 2a AND 2b WITH HIGH VIRAL LOAD (2013) (0)
- 1128 PREDICTION MODEL OF ANEMIA USING ITPA GENOTYPE IDENTIFIES PATIENTS AT HIGH RISK OF ANEMIA AND TREATMENT FAILURE WITH PEGYLATED-INTERFERON PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C (2012) (0)
- Abstract 10931: Serum Mac-2 Binding Protein May be a Potential Biomarker for Diagnosis of Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors (2015) (0)
- Identification of Hepatitis B Virus DNA Polymerase Sequences to Predict Virological Response to Entecavir Therapy (2014) (0)
- [467] PATHOLOGICAL ANALYSIS OF HEPATOCELLULAR MITOCHONDRIA AND OXIDATIVE STRESS IN CHRONIC HEPATITIS C (2007) (0)
- [Analysis of interferon-stimulated genes expression associated with early elimination of HCV RNA]. (2015) (0)
- IV. Hepatitis B treatment: beyond disease control to functional cure (2018) (0)
- The correlations between HBV markers and HBV cccDNA in the patients during Na treatment (2020) (0)
- Three-year assessment of entecavir resistance in chronic hepatitis B patients and the mechanism of viral breakthrough by the resistance substitutions (2008) (0)
- Simulationand Molecular Docking as Determined by Long-Term Clinical Hepatitis B Virus with Viral Breakthrough Mechanism of Entecavir Resistance of (2013) (0)
- Description of a New Hepatitis B Virus C6 Subgenotype Found in the Papua Province of Indonesia and Suggested Renaming of a Tentative C6 Subgenotype Found in the Philippines as Subgenotype C7 (2009) (0)
- Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication (2017) (0)
- Su1000 Hepatoma With HBV Replication Could Attract CX3CR1+ NKG2Dlow NK Cells and CX3CR1+PD-1+ CD8 T Cells (2014) (0)
- Abstract 4811: Analysis of epigenetic alterations in mice with humanized liver after hepatitis virus infection (2011) (0)
- Tu1477 - Performance of Wisteria Floribunda Agglutinin Positive Mac2-Binding Protein as an HCC Biomarker in an Ethnically Diverse Cohort of Patients with Chronic HBV and HCV (2018) (0)
- Kinetics of serum HBsAg and HBcrAg in predicting response to pegylated interferon-based therapy in patients with HBeAg-negative chronic hepatitis B (2017) (0)
- Contents Vol. 46, 2003 (2003) (0)
- Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients (2021) (0)
- [Evaluation of serum PIVKA-II by Lumipulse PrestoII assay]. (2009) (0)
- 104 CDH2 negative esophageal squamous cell carcinoma with cytotoxic T-lymphocyte signatures is a good responder subtype to definitive chemoradiotherapy (2015) (0)
- Efficacy of Daclatasvir/Asunaprevir for Patients with Chronic Hepatitis C 1B Complicated with Renal Insufficiency (2016) (0)
- [Nucleic acid-based testing for hepatitis B viruss infectious disease]. (2005) (0)
- A risk score combining quantitative hepatitis B surface antigen and core-related antigen levels to predict off-therapy relapse after cessation of nucleos(t)ide analogues in patients with chronic hepatitis B (2018) (0)
- SAT-181-Efficacy and safety of glecaprevir/pibrentasvir in patients with severe renal impairment in Japan: A prospective, multicenter study (KTK 49 Liver Study Group) (2019) (0)
- JSH Consensus Kobe 2009: Diagnosis and Treatment of Hepatitis B (2009) (0)
- Contents Vol. 34, 2016 (2016) (0)
- A case of child-to-father transmission of hepatitis B virus in Japan: a rare infection route (2021) (0)
- Complex structural variations in non-human primate hepatitis B virus (2021) (0)
- Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy (2018) (0)
- 651 MICA PLAYS AN OPPOSITE ROLE IN HEPATOCARCINOGENESIS BETWEEN HEPATITIS B AND HEPATITIS C (2013) (0)
- 590 Tracing the pandemic behavior of hepatitis C virus genotype 1B in Japan — association with the widespread injection treatment for schistosomiasis (2003) (0)
- Changes in serum levels of the novel mac-2 binding protein glycosylation isomer and risk of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleos(t)ide analogues (2018) (0)
- Correlation between hepatitis B virus core-related antigens and intrahepatic covalently closed circular DNA levels (2005) (0)
- 642 Outbreak of hepatitis C virus infection through contaminated fibrinogen concentrates in Japan-tracing the source by molecular evolutionary analysis (2003) (0)
- [Predicting sustained virological response in chronic hepatitis C patients treated with pegylated interferon and ribavirin using a novel highly sensitive Real-time detection PCR assay]. (2007) (0)
- Analysis of factors associated with the prognosis of cirrhotic patients who were treated with V2-receptor antagonist for hepatic edema (2020) (0)
- Identification of the novel 3′ UTR sequences of human IL-21 mRNA as potential targets of miRNAs (2017) (0)
- [Clinical manifestations of HBV genotypes]. (2015) (0)
- [421] SUBGENOTYPES BA, C1 AND C2 OF HEPATITIS B VIRUS IN CHINA: CLINICAL AND VIROLOGICAL CHARACTERISTICS (2007) (0)
- [Direct cytopathic effects of particular hepatitis B virus genotypes in immunosuppressive condition]. (2010) (0)
- Corrigendum to “Antiviral activity of novel 2′-fluoro-6′-methylene-carbocyclic adenosine against wild-type and drug-resistant hepatitis B virus mutants” [Bioorg. Med. Chem. Lett. 21 (2011) 6328–6331] (2012) (0)
- 1177 Predicting relapse after cessation of lamivudine monotherapy for chronic hepatitis B virus infection-application of newly developed HBV real-time detection direct test (2003) (0)
- Clinical efficacy of a newly developed high-sensitive hepatitis B core-related antigen assay for monitoring hepatitis B virus reactivation (2020) (0)
- Managing the Risk of Hepatitis B Virus Reactivation in Patients with B-Cell Lymphomas Treated with Obinutuzumab or Rituximab Immunochemotherapy (2017) (0)
- THU-494-MicroRNA-96 in non-B non-C hepatocellular carcinoma (2019) (0)
- International Congress on Terminology and Knowledge Engineeting : 29 September-1 October 1987 Trier (Federal Republic of Germany) (1988) (0)
- Performance of Wisteria floribunda agglutinin-positive Mac2-binding protein as an HCC biomarker in an ethnically diverse cohort of patients with chronic HBV and HCV (2018) (0)
- Novel Cell Culture-Adapted Genotype 2 a Hepatitis C Virus Infectious (2012) (0)
- Improved treatment response and bone density in patients with chronic hepatitis B (CHB) switched to tenofovir alafenamide (TAF) from other nucleos (t)ide analogue: 96-week results from a prospective multinational study (2022) (0)
- Risk of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients with solid tumors who received systemic chemotherapy: two retrospective studies (2020) (0)
- Tu1476 - Changes in Serum Levels of the Novel Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) and Risk of Hepatocellular Carcinoma (HCC) Among Chronic Hepatitis B (CHB) Patients Treated with Nucleos(t)ide Analogues (NA) (2018) (0)
- Host Genetics and Responses to Antiviral Therapy in Chronic Hepatitis C (2016) (0)
- Cytokines and Chemokines Involved in Hepatitis B Surface Antigen Loss in Human Immunodeficiency Virus/Hepatitis B Virus Coinfected Patients (2021) (0)
- Thrombolytic Effect of Human Tissue-type Plasminogen Activator (t-PA, MMR 701) on a Canine Coronary Thrombosis Model (1991) (0)
- [485] ROLE OF HBV GENOTYPES, CORE PROMOTER/PRECORE MUTATIONS AND HBVDNA LEVELS ON HEPATOCARCINOGENESIS (2007) (0)
- [Immune responses to HBV infection]. (2015) (0)
- Breakthrough HBV infection in a vaccinated child due to vaccine escape mutant (2021) (0)
- What's Hot in the Red Journal This Month? (2009) (0)
- 469 ITPA GENE VARIANT PROTECTS AGAINST TREATMENT-INDUCED ANEMIA AND IMPROVES VIRAL CLEARANCE BY PEGYLATED INTERFERON-ALFA AND RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C PATIENTS (2011) (0)
- 3. Hepatitis C virus (2005) (0)
- Is it necessary to revise the liver transplantation guidelines to meet the current situation? (2021) (0)
- P562 ASSESSMENT OF MALIGNANT POTENTIAL OF HEPATIC HYPOVASCULAR NODULES USING COMBINATION IMAGING STUDIES IN PATIENTS WITH CHRONIC LIVER DISEASE (2014) (0)
- An improved droplet digital PCR assay reveals the stability of intrahepatic hepatitis B virus cccDNA. (2021) (0)
- DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC (2022) (0)
- Enhancing functional cure in with of an Interferon-Inducible Regulatory Molecule, IFI44L, for Hepatitis B Virus cccDNA in Primary (2021) (0)
- [Relation of IL28B gene polymorphism to chronic hepatitis C]. (2011) (0)
- Risk factors associated with subclinical atherosclerosis in the patients with biopsy-proven non-alcoholic fatty liver disease (2020) (0)
- MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells (2019) (0)
- P.030 C1858 was specific in HBV genotype C in patients from northern Vietnam but not in Japanese patients (2006) (0)
- Rapid point-of-care test for hepatitis B core-related antigen (HBcrAg) to identify HBV-infected patients eligible for antiviral therapy. (2022) (0)
- Ivermectin Inhibits HBV Entry into the Nucleus by Suppressing KPNA2 (2022) (0)
- 295 - Sustained Virologic Response (SVR) to Direct-Acting Antiviral (DAA) Therapy in Patients with Hepatitis C Virus (HCV) Infection and Hepatocellular Carcinoma (HCC): A Systematic Review and Meta-Analysis (2018) (0)
- Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma (2016) (0)
- Performance of a highly sensitive hepatitis B surface antigen assay among chronic hepatitis B patients after hepatitis B surface antigen seroclearance (2014) (0)
- O2-7-3REACTIVATION OF HEPATITIS B VIRUS (HBV) IN HBV-RESOLVED PATIENTS WITH ADULT T-CELL LEUKEMIA/LYMPHOMA (2014) (0)
- Predictors of HBsAg loss after cessation of nucleo (s)tide analogue therapy in asian patients with low HBsAg levels (2022) (0)
- Application of fluorescent-based technology detecting protein-protein interactions to monitor the binding of hepatitis B virus X protein to DNA-damage-binding protein 1 (2021) (0)
- Recent advances in hepatitis B research and drug development (2017) (0)
- In-depth interviews of non-hepatologists and the achievements made after introducing a "patient referral document for hepatitis" in our hospital (2019) (0)
- Smoking is a risk factor for development of adult T-cell leukemia/lymphoma in Japanese human T-cell leukemia virus type-1 carriers (2016) (0)
- 785 INNATE SIGNALING BY HEPATITIS C VIRUS IS RIG-I AND MDA5 DEPENDENT AND MODULATED BY NS5A DOMAIN II (2012) (0)
- Using Wisteria floribunda agglutinin-positive Mac2-binding protein in combination with the FIB-4 index to predict significant liver fibrosis (2018) (0)
- A case report of successful therapy with tenofovir for a multi-drug resistant chronic hepatitis B patient complicated with malignant lymphoma (2012) (0)
- Longitudinal serologic profiles up to 5 years in hepatitis B surface antigen-negative chronic hepatitis B (2014) (0)
- [Management for reactivation of hepatitis B virus following systemic chemotherapy]. (2012) (0)
- [Clinical implication of hepatitis B virus genotype]. (2011) (0)
- Hepatitis B surface gene variants isolated from blood donors with overt and occult HBV infection in north eastern Egypt (2015) (0)
- Title: Novel Cell Culture-Adapted Genotype 2a Hepatitis C Virus Infectious Clone 1 2 (2012) (0)
- Contents Vol. 49, 2006 (2006) (0)
- The impact of PNPLA3 and TM6SF2 in cirrhosis related complications (2021) (0)
- Host Genetic Factors Control Hepatitis C Virus Infection (2012) (0)
- Evaluation of anti-HBV effect of a novel candidate compound for hepatitis B therapeutics (2016) (0)
- A case of a HBV carrier with HDV superinfection treated by PEG-IFN (2014) (0)
- Serum WFA+−M2BP level as a diagnostic marker of HBV-related HCC: A case-control study (2018) (0)
- Reply to the letter by Bedognetti et al. “Relevance of HBV/HBcAb screening in lymphoma patients treated in the Rituximab era” (2010) (0)
- Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C (2014) (0)
- Subject Index Vol. 49, 2006 (2006) (0)
- Liver Stiffness Measurement Is Useful to Predict Early Recurrence of Hepatocellular Carcinoma after Sustained Virological Responses by Direct Antiviral Agents in Patients with Hepatitis C (2018) (0)
- Chronic Hepatitis C Patients Pegylated Interferon and Ribavirin in Sustained Virological Response to TaqMan HCV Assays for Prediction of and Roche Cobas AmpliPrep / Cobas Abbott RealTime Hepatitis C Virus ( HCV ) (2009) (0)
- 441 THE ITPA GENOTYPE CORRELATES WITH HEMOLYTIC ANEMIA AND OUTCOME AFTER TREATMENT WITH PEGYLATED-INTERFERON AND RIBAVIRIN IN GENOTYPE IB CHRONIC HEPATITIS C (2011) (0)
- Profiles of HBV DNA, ALT, and HBeAg status after stopping lamivudine in patients with HBeAg seroconversion (2007) (0)
- [Clinical manifestations of hepatitis B virus genotypes]. (2004) (0)
- 1. Round-table discussion on usefulness and future perspectives of the genotype research (2005) (0)
- 1168 RESPONSE GUIDED THERAPY BY PEGINTERFERON A2B PLUS RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 2 (2012) (0)
- Analysis of infectious source of acute hepatitis B virus (HBV) infection: Factors affecting the severity of acute hepatitis (2003) (0)
- FRI-174-Discovery of novel therapeutic targets for decreasing HBsAg, focusing on host proteins binding to HBV RNAs (2019) (0)
- An easy method of kiwifruit protease extraction and utilization for chicken meat tenderization (1994) (0)
- Detection of notable hepatitis B virus serologic activity after hepatitis B surface antigen seroclearance (2022) (0)
- Method for increasing the protein concentration of the aqueous solution (1990) (0)
- Comparison of Recombinant Single- and Two-chain Tissue Plasminogen Activator in Clot Binding, Fibrinolysis, and Fibrinogenolysis in Vitro (1994) (0)
- Design, Synthesis and Evaluation of Anti-Hepatitis B Virus (Hbv) Activity of Novel Entecavir Analogues Having 4′-Cyano-6″-Fluoromethylenecyclopentene Skeletons as an Aglycone Moiety (2023) (0)
- Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Yasuhito Tanaka?
Yasuhito Tanaka is affiliated with the following schools:
